Headline News about Gilead Sciences![]() ![]() ![]() ![]() ![]()
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
March 08, 2024
Via Benzinga
Exposures
Product Safety
![]() ![]()
$1000 Invested In This Stock 20 Years Ago Would Be Worth $11,000 Today
February 23, 2024
Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() Via Talk Markets
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![]() ![]() Via Benzinga
![]()
Drugmaker Gilead Sciences Scoops Up Liver-Disease Focused CymaBay Therapeutics For $4.3B
February 12, 2024
Via Benzinga
Exposures
Product Safety
![]() ![]()
Gilead Sciences Stock Approaches Daily Buying Area
February 12, 2024
Via Talk Markets
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|